Allspring Global Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,145
Closed -$255K 1798
2025
Q4
$255K Buy
3,145
+275
+10% +$23.7K ﹤0.01% 1542
2025
Q3
$251K Sell
2,870
-28
-1% -$2.5K ﹤0.01% 1518
2025
Q2
$241K Sell
2,898
-10,167
-78% -$850K ﹤0.01% 1515
2025
Q1
$1.1M Sell
13,065
-256
-2% -$23.8K ﹤0.01% 1232
2024
Q4
$1.23M Buy
13,321
+4,330
+48% +$416K ﹤0.01% 1249
2024
Q3
$835K Sell
8,991
-211
-2% -$18.3K ﹤0.01% 1365
2024
Q2
$757K Buy
9,202
+3,498
+61% +$257K ﹤0.01% 1404
2024
Q1
$379K Sell
5,704
-4,005
-41% -$247K ﹤0.01% 1590
2023
Q4
$551K Sell
9,709
-8,611
-47% -$451K ﹤0.01% 1473
2023
Q3
$998K Buy
18,320
+8,920
+95% +$529K ﹤0.01% 1362
2023
Q2
$632K Buy
9,400
+7
+0.1% +$427 ﹤0.01% 1513
2023
Q1
$483K Buy
9,393
+7,672
+446% +$372K ﹤0.01% 1597
2022
Q4
$79.2K Sell
1,721
-38
-2% -$1.78K ﹤0.01% 2164
2022
Q3
$89K Sell
1,759
-404
-19% -$20.2K ﹤0.01% 2127
2022
Q2
$98K Sell
2,163
-19,826
-90% -$887K ﹤0.01% 2072
2022
Q1
$1.02M Buy
21,989
+119
+0.5% +$5.33K ﹤0.01% 1859
2021
Q4
$1.1M Buy
+21,870
New +$1.13M ﹤0.01% 1881

Other funds holding LMAT

Allspring Global Investments's LMAT Position: Q1 2026 in Review

Allspring Global Investments sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 3,145 shares — an estimated $255K sold.

Allspring Global Investments first reported a position in LMAT in Q4 2021 and held it in 17 quarters. The position peaked at $1.23M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Allspring Global Investments reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Allspring Global Investments sold 3,145 LeMaitre Vascular shares in Q1 2026, an estimated $255K.
  • Allspring Global Investments first reported a position in LeMaitre Vascular in Q4 2021 and held it in 17 quarters.
  • Allspring Global Investments's LeMaitre Vascular position peaked at $1.23M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.